LAVA Therapeutics NV - N51517105

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Description is not available for this instrument yet.

Quarter snapshot

Latest / Compare
Q3 2025 · Q2 2025
Value (USD)
Total reported value ($000)
$16.32M
QoQ value delta ($000)
+$5.673M (+53.31%)
Implied price effect (QoQ)
+18.24%
Shares
Total shares
10,463,325
QoQ shares delta
+2,393,694 (+29.66%)
Total shares held by funds (by quarter)

Top holders (Q3 2025)

Top 25 only Full list
Manager Value ($000) Shares % of 13F
Shay Capital LLC 3,976 2,548,730 0.34%
Redmile Group, LLC 3,236 2,074,372 0.31%
BML Capital Management, LLC 3,074 1,970,610 2.81%
Sanofi 2,994 1,919,455 1.15%
Merck & Co., Inc. 1,792 1,149,345 0.79%
GTS SECURITIES LLC 312 200,000 0.01%
Rangeley Capital, LLC 257 165,000 0.22%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 240 154,300 0.0%
PNC FINANCIAL SERVICES GROUP, INC. 101 65,000 0.0%
CITADEL ADVISORS LLC 83 53,308 0.0%
Lepercq De Neuflize Asset Management LLC 48 31,000 0.03%
EQUITEC PROPRIETARY MARKETS, LLC 43 27,900 0.01%
JBF Capital, Inc. 37 23,911 0.01%
XTX Topco Ltd 33 21,727 0.0%
UBS Group AG 24 15,871 0.0%
TORNO CAPITAL, LLC 23 15,000 0.0%
GEODE CAPITAL MANAGEMENT, LLC 22 14,170 0.0%
JANE STREET GROUP, LLC 19 12,500 0.0%
TSFG, LLC 1 400 0.0%
JONES FINANCIAL COMPANIES LLLP 0 400 0.0%
SBI Securities Co., Ltd. 0 300 0.0%
Smallwood Wealth Investment Management, LLC 0 26 0.0%